Brief: Allovir Reports Q2 Results
06/08/2021 12:20
Aug 6 (Reuters) - Allovir Inc ALVR.O :
* Q2 LOSS PER SHARE $0.60
* Q2 EARNINGS PER SHARE ESTIMATE $-0.49 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nBw5skqf1a
Further company coverage: ALVR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kalaris Therapeutics
See all newsKalaris Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Kalaris Therapeutics Q2 net loss narrows on lower administrative costs
Kalaris Therapeutics Inc expected to post a loss of 49 cents a share - Earnings Preview
Kalaris Therapeutics posts smaller-than-expected Q1 net loss
Brief: Kalaris Therapeutics Inc Q1 Operating Income USD -11.833 Million